Mon - Fri 11 - 7 | Sat 9 - 4 | 1335 Lakeside Dr., Romeoville, IL 60446 630-359-3213

Chronic Inflammatory Demyelinating Polyneuropathy and Cannabis

Treating Chronic Inflammatory Demyelinating Polyneuropathy with Cannabis

Chronic Inflammatory Demyelinating Polyneuropathy

What Is Chronic Inflammatory Demyelinating Polyneuropathy?

Chronic inflammatory demyelinating polyneuropathy, also known as CIDP, is an acquired immune-mediated inflammatory disorder closely associated with Guillain-Barre syndrome. Affecting the peripheral nervous system, this condition is a chronic relapsing polyneuropathy.

Like other autoimmune diseases, as part of CIDP the cells which are supposed to protect the body from infection or other foreign invaders actually attack healthy cells. Chronic inflammatory demyelinating polyneuropathy involves demyelination. This means that the healthy cells attacked within the disorder are nerve cells. Demyelination, destruction and removal of the nerve cells’ protective myelin sheath, is also an aspect of multiple sclerosis. When nerve cells are attacked, they stop responding as they should, slow in their response or respond in a weakened manner.

Also very similar to multiple sclerosis, chronic inflammatory demyelinating polyneuropathy is a relapsing and remitting disorder. This means that a patient might suffer a particularly difficult period of symptom intensification, then after time recover completely. At some point within the disease’s progression, that patient will likely suffer relapses and not remit completely, then suffering resulting permanent damage. This is how the disease progresses over time.

Typical symptoms of chronic inflammatory demyelinating polyneuropathy include:

  • Numbing of the body
  • Tingling sensations, particularly in limbs
  • Pain
  • Progressive muscle weakness and atrophy
  • Loss of deep tendon reflexes
  • Chronic fatigue
  • Other abnormal sensations

Cannabis to Alleviate Chronic Inflammatory Demyelinating Polyneuropathy

Pain is the most common reason why people turn to medical marijuana through an Illinois dispensary for treatment of their diseases and other conditions. Pain caused by chronic inflammatory demyelinating polyneuropathy is similar to other forms of pain, particularly similar to that of multiple sclerosis, which medical marijuana is also used to treat.

Illinois cannabis can help reduce pain and inflammation, as well as tingling sensations, muscle spasms and other issues which may be directly caused by CIDP. Cannabis is also effective in reducing nausea, diarrhea and issues associated with common medications provided for the treatment of chronic inflammatory demyelinating polyneuropathy.

Illinois cannabis is effective toward symptoms of depression, such as sleeplessness, mood swings and other mood issues. Chronic fatigue is often helped by improved sleep patterns and Illinois marijuana helps many patients improve sleep.

While nothing is known to stop progression of chronic inflammatory demyelinating polyneuropathy at this time, medical marijuana can possibly slow progression through its anti-inflammatory properties. Cannabis is a known anti-inflammatory which has a stabilizing effect on the channels which influence severity of immune response. When the body believes itself to be under attack, medical marijuana is believed to be able to suppress the strength of its attack. As CIDP involves the body’s attack on its own healthy cells, suppressing destruction of healthy cells is beneficial. The less those healthy cells are harmed, the less quickly chronic inflammatory demyelinating polyneuropathy can progress.

There are a multitude of symptoms of chronic inflammatory demyelinating polyneuropathy for which Illinois cannabis has been proven beneficial. When diagnosed with a disease like CIDP, patients become aware that slowing progression and alleviating symptoms are not a cure, but they are critical components of disease management for a continued quality of life.

Leave a Reply

Newsletter Signup

Signup to receive exciting news updates and specials.

Enter your first name
Enter your last name
Enter your email
Enter your email